Medicare Enrolled
Dr. Cameron Sikavi, MD
Gastroenterology · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sikavi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sikavi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sikavi
Dr. Cameron Sikavi is a gastroenterology specialist in Torrance, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Sikavi performed 2,662 Medicare services across 1,060 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sikavi received a total of $7,834 from 40 pharmaceutical and/or device companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sikavi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice
▲ Top 5% volume in CA
$7,834 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,662
Medicare services
Top 5% in CA for gastroenterology
1,060
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~266 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,403 | $102 | $219 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
232 | $158 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
219 | $149 | $433 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
151 | $181 | $730 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
147 | $91 | $315 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
104 | $144 | $369 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $113 | $285 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
78 | $80 | $930 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
63 | $68 | $159 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
49 | $164 | $1,073 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $82 | $237 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
25 | $210 | $1,070 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $111 | $331 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $80 | $205 |
| New patient office visit, complex (60-74 min) | 15 | $193 | $490 |
| Endoscopic control of upper GI bleeding A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine. |
14 | $152 | $1,550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,834
Total received (2018-2024)
Avg $1,119/year across 7 years
Top 22% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,649 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$185 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,650
2023
$1,763
2022
$1,050
2021
$512
2020
$335
2019
$670
2018
$1,854
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$223
Janssen Biotech, Inc.
$205
ABBVIE INC.
$194
QOL Medical, LLC
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$105
Regeneron Healthcare Solutions, Inc.
$100
Ardelyx, Inc.
$85
Novartis Pharmaceuticals Corporation
$78
Merck Sharp & Dohme LLC
$67
Braintree Laboratories, Inc.
$53
Alnylam Pharmaceuticals Inc.
$44
GENZYME CORPORATION
$44
Impulse Dynamics (USA) Inc.
$41
Phathom Pharmaceuticals, Inc.
$39
Mirum Pharmaceuticals, Inc.
$37
IRONWOOD PHARMACEUTICALS, INC
$34
GlaxoSmithKline, LLC.
$27
Madrigal Pharmaceuticals
$26
AIMMUNE THERAPEUTICS, INC.
$26
Gilead Sciences, Inc.
$26
Kiniksa Pharmaceuticals International, plc
$24
Intercept Pharmaceuticals, Inc.
$19
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation of the Americas
$949
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$690
ABBVIE INC.
$638
COVIDIEN LP
$633
Takeda Pharmaceuticals U.S.A., Inc.
$613
QOL Medical, LLC
$499
BOSTON SCIENTIFIC CORPORATION
$387
AbbVie Inc.
$367
GENZYME CORPORATION
$349
Janssen Biotech, Inc.
$312
Cook Medical LLC
$292
Janssen Scientific Affairs, LLC
$230
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$194
Celgene Corporation
$189
Regeneron Healthcare Solutions, Inc.
$167
Merck Sharp & Dohme LLC
$134
PFIZER INC.
$124
E.R. Squibb & Sons, L.L.C.
$122
Olympus America Inc.
$98
AbbVie, Inc.
$95
Ardelyx, Inc.
$85
Novartis Pharmaceuticals Corporation
$78
Braintree Laboratories, Inc.
$53
GlaxoSmithKline, LLC.
$52
Ironwood Pharmaceuticals, Inc
$47
Alnylam Pharmaceuticals Inc.
$44
INTERCEPT PHARMACEUTICALS, INC.
$41
Impulse Dynamics (USA) Inc.
$41
Phathom Pharmaceuticals, Inc.
$39
Mirum Pharmaceuticals, Inc.
$37
IRONWOOD PHARMACEUTICALS, INC
$34
Madrigal Pharmaceuticals
$26
AIMMUNE THERAPEUTICS, INC.
$26
Gilead Sciences, Inc.
$26
Amgen Inc.
$25
Kiniksa Pharmaceuticals International, plc
$24
Alcresta Therapeutics, Inc.
$23
Daiichi Sankyo Inc.
$21
Intercept Pharmaceuticals, Inc.
$19
Musculoskeletal Transplant Foundation Inc.
$13
Top 3 companies account for 29.1% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AREXVY · Arcalyst · BRAVO · Cook Medical Hemospray · Cook Medical Hemostasis · DIFICID · DUPIXENT · ENTRESTO · ENTYVIO · EVENITY · EVIS EXERA · GATTEX · GENERAL - THERAPIES · HUMIRA · Hemospray · IBSRELA · INJECTAFER · LifeVest · Linzess · Livmarli · MANOMETRY · Mavyret · OCALIVA · Olympus EndoTherapy Accessories · Optimizer · PILLCAM · RELISTOR · RELIZORB · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUTAB · Sucraid · TOUJEO · TREMFYA · TRULANCE · VERQUVO · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
400
Per 100K population
4.1
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sikavi is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sikavi experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Sikavi performed 1,403 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sikavi receive payments from pharmaceutical companies?
Yes. Dr. Sikavi received a total of $7,834 from 40 companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sikavi's costs compare to other gastroenterologists in Torrance?
Dr. Sikavi's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sikavi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Torrance
Browse gastroenterologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology